Last reviewed · How we verify
Acquired partial lipodystrophy
Approved treatments
- Myalept · Amylin Pharms Llc
Myalept works by mimicking the action of leptin, a hormone that regulates fat distribution and metabolism.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acquired partial lipodystrophy patent landscape — cliff calendar, originator estates, attackable patents
- Acquired partial lipodystrophy treatment landscape brief
- Acquired partial lipodystrophy treatment updates RSS
Frequently asked questions about Acquired partial lipodystrophy
What drugs treat Acquired partial lipodystrophy?
Tracked treatments include Myalept.
What is the treatment for Acquired partial lipodystrophy?
Standard treatment for Acquired partial lipodystrophy includes Myalept. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Acquired partial lipodystrophy patent cliff · Acquired partial lipodystrophy CI report
- Treatment: Myalept · Amylin Pharms Llc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing